California Families Battle Texas Subpoenas for Trans Youth Medical Records – But Media Ignores the Fraud Probe Behind Them

A group of California families with transgender-identifying children filed suit last week in the U.S. District Court for the Northern District of California, demanding that Lucile Packard Children’s Hospital at Stanford be blocked from turning over sensitive medical records to a federal grand jury in Texas. The families, represented by LGBTQ activist groups, portray the subpoenas as an outrageous “authoritarian grab” at children’s privacy by the Trump DOJ.

But a closer look reveals the real story the activist media refuses to tell. This is part of a legitimate, nationwide federal investigation into potential healthcare fraud, off-label drug promotion, and false billing tied to experimental gender interventions on minors, interventions that multiple European countries have already sharply restricted after finding the evidence base dangerously weak.

Since July 2025, the Department of Justice has issued more than 20 subpoenas to hospitals and clinics providing puberty blockers, cross-sex hormones, and related care to minors. When many providers resisted through civil challenges, prosecutors turned to grand jury subpoenas out of the Northern District of Texas, a venue with clear jurisdiction over federal fraud investigations.

This probe is national in scope, and California, along with a handful of other progressive strongholds, has become a destination for interstate “medical tourism.” With 27 states now restricting or banning these interventions for minors, families from restrictive states increasingly travel to California providers like Stanford for the very treatments now under scrutiny.

Providers themselves report that roughly one-third of their gender-affirming care patients come from out of state precisely because of these laws. A federal court in Texas enforcing subpoenas for records generated across state lines is not “forum-shopping”, a legal term of art used by fear mongering progressives to paint the actions in a more fascist light. It is the logical consequence of California’s self-proclaimed “sanctuary” status for experimental, and often barbaric, medical practices on minors.

The core of the DOJ’s investigation is straightforward. Puberty blockers and cross-sex hormones are not FDA-approved for treating gender dysphoria in minors. They are approved for other conditions, such as precocious puberty, endometriosis, or prostate cancer. However, clinics allegedly code and bill these powerful, sterilizing drugs under approved indications or use vague “endocrine disorder” codes to secure Medicaid and private insurance reimbursement that would otherwise be denied.

The first major resolution proves the point. In May 2026, Texas Children’s Hospital agreed to pay over $10 million in damages and penalties to settle allegations it submitted false billings for gender-transition procedures on minors. The hospital also committed to ending such care for children and establishing a dedicated detransition clinic, the first of its kind in the nation.

DOJ and Texas AG Ken Paxton explicitly cited violations of the Federal Food, Drug, and Cosmetic Act (FDCA), the False Claims Act (FCA), and related fraud statutes. This is not abstract ideology. It is alleged systematic misrepresentation to insurers and taxpayers.

Contrast this reality with coverage in The Advocate, a far-left LGBT media outlet that often spreads propaganda. In a recent article, the outlet presents the lawsuit as pure victimhood. Not once does the piece mention the fraud investigation, off-label prescribing concerns, the Texas Children’s Hospital settlement, or any judicial rationale for the subpoenas.

Instead, it amplifies alarmist quotes designed to terrify parents: